These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18833664)

  • 21. Usefulness of in-hospital change in B-type natriuretic peptide levels in predicting long-term outcome in elderly patients admitted for decompensated heart failure.
    Cournot M; Leprince P; Destrac S; Ferrières J
    Am J Geriatr Cardiol; 2007; 16(1):8-14. PubMed ID: 17215637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification.
    Faggiano P; Valle R; Aspromonte N; D'Aloia A; Di Tano G; Barro S; Giovinazzo P; Milani L; Lorusso R; Dei Cas L
    Int J Cardiol; 2010 Apr; 140(1):88-94. PubMed ID: 19321212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysis.
    Salah K; Pinto YM; Eurlings LW; Metra M; Stienen S; Lombardi C; Tijssen JG; Kok WE
    Am Heart J; 2015 Sep; 170(3):531-42.e1. PubMed ID: 26385037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative evaluation of B-type natriuretic peptide and mid-regional pro-A-type natriuretic peptide changes from admission to discharge in prognosis of acute decompensated heart failure patients.
    Stenner E; Buiatti A; Barbati G; Merlo M; Sinagra G; Biasioli B
    Clin Lab; 2012; 58(5-6):585-9. PubMed ID: 22783593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Impact of BNP Variations in Patients Admitted for Acute Decompensated Heart Failure with In-Hospital Worsening Renal Function.
    Stolfo D; Stenner E; Merlo M; Porto AG; Moras C; Barbati G; Aleksova A; Buiatti A; Sinagra G
    Heart Lung Circ; 2017 Mar; 26(3):226-234. PubMed ID: 27523462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Natriuretic peptides--new diagnostic markers in heart disease].
    Angermann CE; Ertl G
    Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of galectin-3 and plasma B type-natriuretic peptide in predicting prognosis in discharged chronic heart failure patients.
    Feola M; Testa M; Leto L; Cardone M; Sola M; Rosso GL
    Medicine (Baltimore); 2016 Jun; 95(26):e4014. PubMed ID: 27368017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The predictive value of plasma biomarkers in discharged heart failure patients: role of plasma NT-proBNP.
    Leto L; Testa M; Feola M
    Minerva Cardioangiol; 2016 Apr; 64(2):157-64. PubMed ID: 26373781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure.
    Khanam SS; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Yoo BS
    BMC Cardiovasc Disord; 2017 Aug; 17(1):215. PubMed ID: 28774268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study.
    Khalid U; Wruck LM; Quibrera PM; Bozkurt B; Nambi V; Virani SS; Jneid H; Agarwal S; Chang PP; Loehr L; Basra SS; Rosamond W; Ballantyne CM; Deswal A
    Int J Cardiol; 2017 Apr; 233():61-66. PubMed ID: 28185703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure.
    Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Verdiani V; Tijssen JG; Pinto YM
    JACC Heart Fail; 2015 Oct; 3(10):751-61. PubMed ID: 26449995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
    Fonarow GC; Peacock WF; Phillips CO; Givertz MM; Lopatin M;
    J Am Coll Cardiol; 2007 May; 49(19):1943-50. PubMed ID: 17498579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting short-term mortality in advanced decompensated heart failure - role of the updated acute decompensated heart failure/N-terminal pro-B-type natriuretic Peptide risk score.
    Scrutinio D; Ammirati E; Passantino A; Guida P; D'Angelo L; Oliva F; Ciccone MM; Iacoviello M; Dentamaro I; Santoro D; Lagioia R; Sarzi Braga S; Guzzetti D; Frigerio M
    Circ J; 2015; 79(5):1076-83. PubMed ID: 25753469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B-type natriuretic peptide may predict prognosis in older adults admitted with a diagnosis other than heart failure.
    Di Marca S; Rando A; Cataudella E; Pulvirenti A; Alaimo S; Terranova V; Corriere T; Pisano M; Di Quattro R; Ronsisvalle ML; Giraffa CM; Giordano M; Stancanelli B; Malatino L
    Nutr Metab Cardiovasc Dis; 2018 Jun; 28(6):636-642. PubMed ID: 29625779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.
    Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Damman P; Tijssen JG; Pinto YM
    Heart; 2014 Jan; 100(2):115-25. PubMed ID: 24179162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
    Cohen-Solal A; Logeart D; Huang B; Cai D; Nieminen MS; Mebazaa A
    J Am Coll Cardiol; 2009 Jun; 53(25):2343-8. PubMed ID: 19539144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Admission and predischarge levels of NT pre brain natriuretic peptide in patients hospitalized because of worsening heart failure. relation to risk of death in the next 6-12 months].
    Mazovets OL; Trifonov IR; Katrukha AG; Gratsianskiĭ NA
    Kardiologiia; 2009; 49(1):34-8. PubMed ID: 19166399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide show a different profile in response to acute decompensated heart failure treatment.
    Di Somma S; Magrini L; Tabacco F; Marino R; Talucci V; Marrocco F; Cardelli P; Ferri E; Pittoni V
    Congest Heart Fail; 2008; 14(5):245-50. PubMed ID: 18983287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fall in readmission rate for heart failure after implementation of B-type natriuretic peptide testing for discharge decision: a retrospective study.
    Valle R; Aspromonte N; Carbonieri E; D'Eri A; Feola M; Giovinazzo P; Noventa F; Prevaldi C; Barro S; Milani L
    Int J Cardiol; 2008 Jun; 126(3):400-6. PubMed ID: 17804095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain natriuretic peptide at discharge as a predictor of 6-month mortality in acute decompensated heart failure.
    Naffaa M; Makhoul BF; Tobia A; Jarous M; Kaplan M; Aronson D; Saliba W; Azzam ZS
    Am J Emerg Med; 2014 Jan; 32(1):44-9. PubMed ID: 24210886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.